Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 1.855 USD -0.8% Market Closed
Market Cap: $103.5m

Net Margin

-504.1%
Current
Improving
by 52.9%
vs 3-y average of -557%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-504.1%
=
Net Income
$-82.1m
/
Revenue
$16.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-504.1%
=
Net Income
$-82.1m
/
Revenue
$16.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Seer Inc
NASDAQ:SEER
105.3m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.9B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
81.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
275.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.6B EUR
Loading...

Market Distribution

Lower than 91% of companies in the United States of America
Percentile
9th
Based on 15 072 companies
9th percentile
-504.1%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Seer Inc
Glance View

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
1.243 USD
Overvaluation 33%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-504.1%
=
Net Income
$-82.1m
/
Revenue
$16.3m
What is Seer Inc's current Net Margin?

The current Net Margin for Seer Inc is -504.1%, which is above its 3-year median of -557%.

How has Net Margin changed over time?

Over the last 3 years, Seer Inc’s Net Margin has increased from -695.7% to -504.1%. During this period, it reached a low of -695.7% on May 30, 2022 and a high of -504.1% on Jul 30, 2025.

Back to Top